Published in Biol Pharm Bull on June 01, 2005
The journal impact factor: too much of an impact? Ann Acad Med Singapore (2006) 2.98
Herb-drug interactions: a literature review. Drugs (2005) 2.59
Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma. Mol Cancer Ther (2007) 2.01
Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet (2009) 1.96
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat Immunol (2013) 1.95
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
The effect of photodynamic therapy on tumor angiogenesis. Cell Mol Life Sci (2009) 1.62
A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res (2003) 1.60
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clin Cancer Res (2008) 1.57
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol (2003) 1.55
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res (2011) 1.49
Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res (2004) 1.47
Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther (2010) 1.45
Postoperative endocrine function in patients with surgically treated thyrotoxicosis. Head Neck (2004) 1.42
Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm (2005) 1.38
General Surgery (GS) Residency Selection Process: A Comparison Between Singapore (Singhealth) and United States. Ann Acad Med Singapore (2014) 1.38
Reduced graphene oxide conjugated Cu2O nanowire mesocrystals for high-performance NO2 gas sensor. J Am Chem Soc (2012) 1.38
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Cell Mol Med (2009) 1.30
Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol (2007) 1.29
Nanoparticles in photodynamic therapy. Chem Rev (2015) 1.26
Laser confocal endomicroscopy as a novel technique for fluorescence diagnostic imaging of the oral cavity. J Biomed Opt (2007) 1.25
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma. J Cell Mol Med (2008) 1.19
Ultrasensitive near-infrared Raman reporters for SERS-based in vivo cancer detection. Angew Chem Int Ed Engl (2011) 1.18
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). J Hepatol (2009) 1.12
Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol (2011) 1.10
Xenografts of human hepatocellular carcinoma: a useful model for testing drugs. Clin Cancer Res (2006) 1.07
Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor. Mol Cancer Ther (2009) 1.07
Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol (2009) 1.05
Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J Drug Target (2009) 1.01
Primary malignant melanoma of the esophagus with multiple esophageal lesions. Nat Clin Pract Gastroenterol Hepatol (2007) 1.00
Multiplex cancer cell detection by SERS nanotags with cyanine and triphenylmethine Raman reporters. Chem Commun (Camb) (2011) 0.99
Art and science of photodynamic therapy. Clin Exp Pharmacol Physiol (2006) 0.99
Cancer trends and incidences in Singapore. Jpn J Clin Oncol (2013) 0.97
The future of medical diagnostics: review paper. Head Neck Oncol (2011) 0.97
Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells. Int J Oncol (2002) 0.96
Investigation of high shear wet granulation processes using different parameters and formulations. Chem Pharm Bull (Tokyo) (2008) 0.96
Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomedicine (2007) 0.95
Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer (2008) 0.95
Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. Mol Cancer Ther (2007) 0.95
Hypocrellins and Hypericin induced apoptosis in human tumor cells: a possible role of hydrogen peroxide. Int J Mol Med (2002) 0.95
Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study. Lasers Surg Med (2008) 0.94
Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection. Biosens Bioelectron (2010) 0.94
Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization. Int J Pharm (2006) 0.94
Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma. Angiogenesis (2011) 0.93
AZD6244 (ARRY-142886) enhances the therapeutic efficacy of sorafenib in mouse models of gastric cancer. Mol Cancer Ther (2009) 0.93
Concentration dependence of gold nanoshells on the enhancement of optical coherence tomography images: a quantitative study. Appl Opt (2009) 0.92
Mechanistic study on hydration and drug release behavior of sodium alginate compacts. Drug Dev Ind Pharm (2007) 0.92
Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins. Photochem Photobiol Sci (2007) 0.92
Optimization of process parameters for a quasi-continuous tablet coating system using design of experiments. AAPS PharmSciTech (2010) 0.92
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma. Ann Acad Med Singapore (2013) 0.92
A global partnership in medical education between Duke University and the National University of Singapore. Acad Med (2008) 0.91
The use of digitized endoscopic imaging of 5-ALA-induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo. Int J Cancer (2004) 0.91
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma. J Hepatol (2011) 0.90
Clinical SERS: are we there yet? J Biophotonics (2011) 0.90
Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Mol Cancer (2009) 0.90
Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model. Cancer Lett (2006) 0.90
Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary. J Gynecol Oncol (2011) 0.90
Development of highly reproducible nanogap SERS substrates: comparative performance analysis and its application for glucose sensing. Biosens Bioelectron (2010) 0.89
Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. J Environ Pathol Toxicol Oncol (2008) 0.89
Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. J Photochem Photobiol B (2005) 0.89
Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Eur J Pharm Biopharm (2008) 0.88
Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer. Cancer Lett (2005) 0.88
Highly sensitive SERS detection of cancer proteins in low sample volume using hollow core photonic crystal fiber. Biosens Bioelectron (2012) 0.88
Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone. J Photochem Photobiol B (2006) 0.87
Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Int J Oncol (2003) 0.87
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother Pharmacol (2005) 0.87
Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer. Int J Oncol (2003) 0.87
Understanding disintegrant action by visualization. J Pharm Sci (2012) 0.86
The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy. Photochem Photobiol Sci (2006) 0.86
2011 Young Surgeon's Award Winner: high endothelial venules: a novel prognostic marker in cancer metastasis and the missing link? Ann Acad Med Singapore (2012) 0.86
Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices. Eur J Pharm Sci (2008) 0.86
Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int J Mol Med (2005) 0.86
Optimal excitation-emission wavelengths for autofluorescence diagnosis of bladder tumors. Int J Cancer (2003) 0.85
Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. J Biomed Opt (2010) 0.85
Clinical validation of a customized multiple signature microarray for breast cancer. Clin Cancer Res (2008) 0.85
Control of optical contrast using gold nanoshells for optical coherence tomography imaging of mouse xenograft tumor model in vivo. J Biomed Opt (2009) 0.85
Confocal endomicroscopic imaging of normal and neoplastic human tongue tissue using ALA-induced-PPIX fluorescence: a preliminary study. Oncol Rep (2004) 0.85
Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano (2015) 0.85
Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol Cancer (2008) 0.84
Frequency shifts in SERS for biosensing. ACS Nano (2012) 0.83
Sensitive multiplex detection of serological liver cancer biomarkers using SERS-active photonic crystal fiber probe. J Biophotonics (2013) 0.83
Photolon™ --photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol (2011) 0.83
Liquid phase coating to produce controlled-release alginate microspheres. J Microencapsul (2005) 0.83
Fluorescence detection of bladder cancer using urine cytology. Int J Oncol (2007) 0.83
Polymer-based microfluidics with surface-enhanced Raman-spectroscopy-active periodic metal nanostructures for biofluid analysis. J Biomed Opt (2008) 0.83
Tobacco: deadly in any form or disguise. Lancet (2006) 0.83